Team:Freiburg/Highlights/2
From 2013.igem.org
(Difference between revisions)
Line 169: | Line 169: | ||
width:500px; | width:500px; | ||
float: left; | float: left; | ||
- | margin:- | + | margin:-20px; |
} | } | ||
Line 316: | Line 316: | ||
<div class="slide-right-col"> | <div class="slide-right-col"> | ||
- | + | <div id="right_column"> <p id="headline"> | |
Activation | Activation | ||
</p> | </p> | ||
Line 323: | Line 323: | ||
For activation we choosed VP-16 as effector. Through the transactivating function of VP-16 the expression of these genes will be enhanced.<br> | For activation we choosed VP-16 as effector. Through the transactivating function of VP-16 the expression of these genes will be enhanced.<br> | ||
We achieved up to 30-fold activation. | We achieved up to 30-fold activation. | ||
- | </p> | + | </p> </div> |
</div> | </div> | ||
<div class=clear></div> | <div class=clear></div> | ||
Line 348: | Line 348: | ||
</div> | </div> | ||
<div class="slide-right-col"> | <div class="slide-right-col"> | ||
- | <div id="right_column | + | <div id="right_column"> |
<p id="headline"> | <p id="headline"> | ||
Repression | Repression |
Revision as of 12:41, 4 October 2013
HIGHLIGHTS